Lemaitre Vascular (LMAT) Interest & Investment Income (2010 - 2026)
Lemaitre Vascular (LMAT) reported Interest & Investment Income of $3.3 million for Q1 2026, up 14.5% year-over-year from $2.9 million in Q1 2025, and down 0.69% quarter-over-quarter from $3.3 million in Q4 2025.
Lemaitre Vascular (LMAT) Interest & Investment Income (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Interest & Investment Income data on file, last reported at $3.3 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $3.3 million, up 14.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (up 97.27% YoY), and the FY2025 annual result was $13.1 million, up 164.58% from the prior year.
- Interest & Investment Income declined to $3.3 million in Q1 2026 per LMAT's latest filing, from $3.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.9 million in Q3 2025 and troughed at $108000.0 in Q1 2022.
- A 5-year average of $1.5 million and a median of $1.0 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income jumped 16600.0% in 2022, then gained 14.5% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $447000.0 in 2022, then surged by 121.92% to $992000.0 in 2023, then jumped by 62.3% to $1.6 million in 2024, then surged by 107.89% to $3.3 million in 2025, then decreased by 0.69% to $3.3 million in 2026.
- Business Quant data shows LMAT's Interest & Investment Income at $3.3 million in Q1 2026, $3.3 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 992,000.00 |
| Sep 30, 2023 | 835,000.00 |
| Jun 30, 2023 | 682,000.00 |
| Mar 31, 2023 | 568,000.00 |
| Dec 31, 2022 | 447,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2022 | 108,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 1,000.00 |